Dr. Nishant Kumar Rana

From Wikivora
Jump to navigation Jump to search


Dr. Nishant Kumar Rana

Senior Postdoctoral Fellow | Department of Medicine, Medical Oncology | University of Colorado Anschutz Medical Campus, USA
Born 19 November 1983
Birth Place India
Nationality Indian
Occupation Senior Postdoctoral Fellow, Biomedical Researcher, Cancer Biologist
Specialisation Cancer Biology, Hypoxia, Postpartum Breast Cancer, Sickle Cell Disease, Pulmonary Hypertension, Neurodegeneration, miRNA Regulation
Institution University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Department Department of Medicine — Division of Medical Oncology
Qualifications Ph.D. (Banaras Hindu University), ICMR Research Associate, UGC Research Fellow, CSIR/UGC NET (Ranks 23 & 30), GATE 2012 (AIR 266)
Known for Postpartum Breast Cancer Research, Sickle Cell Disease PH Research, 20+ Publications, ICMR Fellowship 2022, SEMA7A Research
City Aurora, Denver, Colorado, United States
Google Scholar Scholar Profile
ResearchGate ResearchGate Profile
LinkedIn Dr. Nishant Rana

Dr. Nishant Kumar Rana is an Indian biomedical researcher, cancer biologist and Senior Postdoctoral Fellow in the Department of Medicine, Division of Medical Oncology at the University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. Born on 19 November 1983, his scientific journey is one of remarkable intellectual breadth, disciplined curiosity and a deep, unwavering passion for understanding how living cells respond to stress — and how those responses drive some of the world's most complex and devastating diseases. From the molecular mechanisms of cancer to the vascular havoc wreaked by Sickle Cell Disease, from the mysteries of Parkinson's Disease to the understudied tragedy of Postpartum Breast Cancer — Dr. Nishant Kumar Rana has pursued each question with the rigour of a scientist and the dedication of someone who genuinely believes that research can change — and save — lives.

He holds the prestigious ICMR Research Associate Fellowship (2022), the UGC Research Fellowship and has qualified CSIR/UGC NET with ranks 23 and 30 — among India's most competitive academic benchmarks. He also qualified GATE 2012 with AIR 266 — a testament to his exceptional foundational scientific preparation. His publication record spans 20+ peer-reviewed papers across Cancer Biology, Sickle Cell Disease, Neurodegeneration and molecular physiology — including first-author publications in internationally recognised journals.

Background

Dr. Nishant Kumar Rana was born on 19 November 1983 in India. From the very beginning of his scientific journey, he demonstrated a rare combination of intellectual ambition and methodical persistence — qualities that have carried him from the laboratories of Banaras Hindu University to the cutting-edge research environment of the University of Colorado Anschutz Medical Campus. His path has been shaped by years of competitive examinations, rigorous training, competitive fellowships and a constant, restless drive to ask harder and more meaningful scientific questions.

What makes Dr. Rana's journey particularly inspiring is not just the prestige of his positions or the length of his publication list — but the coherence of purpose that runs through every chapter of his career. Whether studying how cancer cells exploit low-oxygen environments to survive and spread, how Sickle Cell Disease damages the lungs through haemolysis, or how a molecule called SEMA7A helps tumour cells adapt during the devastating postpartum period — every question he has asked is ultimately the same question: How do cells respond to stress — and how can we use that knowledge to fight disease?

Education and Academic Qualifications

  • Ph.D. in Life Sciences / Cancer Biology — Banaras Hindu University (BHU), Varanasi, India — Focused on hypoxia-driven reprogramming of breast cancer cells
  • M.Sc. in Biotechnology — Supported by DBT Scholarship — one of India's most competitive postgraduate science fellowships
  • JNU CEEB 2007 — All India Rank 39 — qualifying for postgraduate studies at Jawaharlal Nehru University — one of India's premier research institutions
  • CSIR/UGC NET-LS Qualified — Ranks 23 and 30 — among India's most competitive national eligibility examinations for research and academia
  • GATE 2012 Qualified — All India Rank 266 — Graduate Aptitude Test in Engineering

Research Journey

The Beginning — Molecular Cloning and Foundational Science

Dr. Nishant Kumar Rana began his scientific career with molecular cloning — performing PCR amplification and molecular cloning of an α-amylase gene from Thermomyces lanuginosus. This foundational work established his technical grounding in Molecular Biology techniques that would serve him throughout his career.

UGC Project Fellow — Anticancer Properties of Natural Compounds

As a UGC-sponsored Project Fellow, he investigated the anticancer properties of Dendrobium species leaf extracts and several synthetic compounds on lymphoma and various cancer cell lines — resulting in multiple peer-reviewed publications. This early work introduced him to Cancer Biology — a field that would become the central thread of his research career.

Ph.D. at Banaras Hindu University — Hypoxia and Breast Cancer

Dr. Rana's doctoral research at Banaras Hindu University was a landmark chapter in his scientific development. His Ph.D. focused on a deeply important and clinically relevant question: how does Hypoxia — a condition of low oxygen — reprogram breast cancer cells to make them more aggressive, more treatment-resistant and more likely to spread?

He demonstrated that CoCl2-driven chemical hypoxia promotes cancer cell proliferation in a concentration and cell-type-dependent manner. He profiled hypoxia-regulated miRNAs in T-47D breast cancer cells — identifying their critical roles in activating angiogenic pathways and suppressing apoptosis (programmed cell death). This work produced two first-author publications and nine collaborative articles — and gave him deep expertise in gene expression analysis, hypoxia modelling, miRNA biology and functional cancer assays. During this period, he also mentored postgraduate and undergraduate researchers — demonstrating his commitment to scientific education alongside research.

Research Associate at BHU — Parkinson's Disease and Neurodegeneration

After completing his Ph.D., Dr. Rana expanded his scientific horizons into Neurodegeneration — joining the Institute of Medical Sciences, BHU as a Research Associate. Here, he characterised miRNA signatures in Parkinson's Disease patients across different environmental regions — investigating how epigenetic and post-transcriptional regulatory mechanisms contribute to neurodegeneration. This work resulted in a first-author publication and established his credentials as a researcher capable of working across disease boundaries.

ICMR Research Associate — Chemopreventive Research and Ferroptosis

As an ICMR Research Associate, Dr. Rana investigated the synergistic chemopreventive effects of natural and synthetic compounds under hypoxic conditions in breast cancer cells — building directly on his doctoral expertise while exploring new therapeutic strategies. He also contributed to a book chapter on ferroptosis modulators in Alzheimer's Disease — reflecting the continuing breadth of his scientific interests and contributions.

Postdoctoral Fellowship — University of Colorado, USA (2023–Present)

In 2023, Dr. Nishant Kumar Rana joined Dr. David Irwin's laboratory at the University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States — bringing his expertise to one of the world's leading biomedical research environments. His work in this laboratory has focused on iron metabolism, free haemoglobin and heme toxicity in Sickle Cell Disease–associated Pulmonary Hypertension (SCD–PH) — a serious and underserved complication of sickle cell disease that damages the lungs through haemolysis-driven vascular remodelling.

His contributions in this laboratory include:

  • Evaluating engineered haemoglobin and heme scavenger complexes — including PEG–apoHb, haptoglobin/hemopexin and ferroportin inhibitor/transferrin — for their ability to mitigate SCD–PH
  • Characterising metabolic and proteomic alterations in the spleen and liver of SCD and β-thalassaemia mice using multi-omics profiling (Proteomics, Metabolomics, RNA-seq)
  • Identifying macrophage recruitment dynamics in Pulmonary Hypertension
  • Utilising in vivo disease models (HbSS–Berk), haemodynamic analysis and precision-cut lung slices (PCLS)

This work has resulted in a first-author publication (March 2025) and five co-authored publications — with additional first-author and collaborative manuscripts currently in preparation.

Senior Postdoctoral Fellow — Postpartum Breast Cancer Research

Most recently, Dr. Rana has joined a new research team as a Senior Postdoctoral Fellow — focusing on one of the most clinically urgent and scientifically underexplored areas in Oncology: Postpartum Breast Cancer. This is a particularly aggressive and devastating form of Breast Cancer that occurs in women following childbirth — a period when the breast undergoes dramatic biological changes as it involutes (returns to a non-lactating state).

His current research centres on exploring Semaphorin 7A (SEMA7A) as a key factor in how tumour cells adapt during postpartum Involution — investigating how this molecule enables cancer cells to survive, adapt and metastasise during this vulnerable period. This work has the potential to unlock entirely new therapeutic strategies for a form of cancer that disproportionately affects young mothers.

Research Expertise

Dr. Nishant Kumar Rana brings deep and broad expertise across the following scientific domains:

Awards and Academic Honours

  • ICMR Research Associate Fellowship (2022) — Indian Council of Medical Research — one of India's most prestigious biomedical research fellowships
  • UGC Research Fellowship (2015–2016) — University Grants Commission Research Fellowship
  • UGC Project JRF/SRF (2012–2015) — Junior and Senior Research Fellowship
  • First Prize — Oral Presentation — International Conference on Recent Trends in Animal Sciences (2022)
  • CSIR/UGC NET-LS Qualified — Ranks 23 and 30
  • GATE 2012 Qualified — All India Rank 266
  • DBT Scholarship — Department of Biotechnology Scholarship for M.Sc.
  • JNU CEEB 2007 — All India Rank 39

Vision and Goals

Dr. Nishant Kumar Rana's scientific vision is as clear as it is ambitious:

I aim to further integrate molecular, functional genomics, and proteomics approaches to understand how stress signals reprogram cellular processes and to develop therapeutic strategies for complex diseases such as cancer.

He is committed to building a research programme that bridges fundamental mechanistic biology and translational Medicine — using the tools of modern Genomics, Proteomics and in vivo modelling to develop therapies that can genuinely improve the lives of patients with cancer, Sickle Cell Disease and other complex conditions.

His deeper personal mission — the one that has driven every experiment, every fellowship application and every late night in the laboratory — is the conviction that science, done with integrity and passion, can change the world. One discovery at a time.

Online Presence


See Also

Retrieved from "https://wikivora.org/index.php?title=Dr._Nishant_Kumar_Rana&oldid=1096"